The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 27, 2006
Filed:
Mar. 08, 2004
Val Goodfellow, Encinitas, CA (US);
Martin Rowbottom, La Jolla, CA (US);
Brian P Dyck, San Diego, CA (US);
Junko Tamiya, Oceanside, CA (US);
Mingzhu Zhang, San Diego, CA (US);
Jonathan Grey, San Diego, CA (US);
Troy D Vickers, San Diego, CA (US);
Mehrak Kiankarimi, San Diego, CA (US);
Warren Wade, San Diego, CA (US);
Sarah Clough, San Diego, CA (US);
Joseph Pontillo, San Diego, CA (US);
Dongpei Wu, San Diego, CA (US);
Val Goodfellow, Encinitas, CA (US);
Martin Rowbottom, La Jolla, CA (US);
Brian P Dyck, San Diego, CA (US);
Junko Tamiya, Oceanside, CA (US);
Mingzhu Zhang, San Diego, CA (US);
Jonathan Grey, San Diego, CA (US);
Troy D Vickers, San Diego, CA (US);
Mehrak Kiankarimi, San Diego, CA (US);
Warren Wade, San Diego, CA (US);
Sarah Clough, San Diego, CA (US);
Joseph Pontillo, San Diego, CA (US);
Dongpei Wu, San Diego, CA (US);
Neurocrine Biosciences, Inc., San Diego, CA (US);
Abstract
Melanin-concentrating hormone (MCH) receptor antagonists are disclosed having utility for the treatment of MCH receptor-based disorders such as obesity. The compounds of this invention have the following structure: including stereoisomers and pharmaceutically acceptable salts thereof, wherein n, R, R, R, R, R, and Rare as defined herein. Pharmaceutical compositions containing a compound of this invention, as well as methods relating to the use thereof, are also disclosed.